API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Aspirin Pellets DR (Delayed Release) are formulated in a way to provide targeted release of aspirin in the intestine, minimizing gastric irritation commonly associated with conventional formulations. These enteric-coated pellets offer consistent drug delivery, improved patient compliance, and are ideal for use in capsule or sachet dosage forms.
| Component | Function |
|---|---|
| Aspirin (Acetylsalicylic Acid) | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Eudragit L30D-55 or Eudragit S100 | Enteric coating polymer – Delayed release |
| Triethyl Citrate / PEG 6000 | Plasticizer (for enteric coating) |
| Talc | Anti-sticking agent in coating |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Aspirin Pellets DR or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Aspirin Pellets DR are enteric-coated pellets designed to delay the release of aspirin until it reaches the intestine. This formulation helps minimize gastric irritation by preventing aspirin from dissolving in the acidic environment of the stomach.
These pellets are commonly used in the production of oral solid dosage forms such as capsules or sachets. They are ideal for patients requiring anti-inflammatory, analgesic, or antiplatelet therapy with improved gastrointestinal tolerability.
Yes, Salius Pharma offers customized Aspirin Pellets DR solutions tailored to client specifications. Whether you require specific release profiles, pellet sizes, or regulatory-compliant formulations for different markets, we work closely with our manufacturing partners to deliver high-quality, market-ready products.